Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Femiplex
- Development stage
- Unknown
- Lead developer
- Charak
- Administration
- Oral, Topical
01
Overview
Femiplex is a proprietary Ayurvedic herbal formulation developed by Charak. It is available in both oral (tablet) and topical (gel) dosage forms and is primarily indicated for the treatment of recurrent vaginitis and leucorrhoea (excessive vaginal discharge). The formulation contains a blend of natural astringents, antimicrobial, and anti-inflammatory herbs, including Ashoka (*Saraca asoca*), Lodhra (*Symplocos racemosa*), Gokshura (*Tribulus terrestris*), Daruharidra (*Berberis aristata*), and Neem (*Azadirachta indica*). These ingredients work synergistically to control abnormal vaginal discharge, maintain vaginal pH balance, relieve itching and burning sensations, and strengthen the body's natural defenses against recurrent vaginal infections.
- Brand names
- FemiplexFemiplex GelFemiplex Tablet
Beyond the preview
Go deeper on Femiplex.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Femiplex.